The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial : Journal of the American Society of Nephrology

Journal Logo

Clinical Research

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial

Saglimbene, Valeria1,2; Palmer, Suetonia C.3; Ruospo, Marinella2; Natale, Patrizia2,4; Maione, Ausilia5; Nicolucci, Antonio6; Vecchio, Mariacristina7; Tognoni, Gianni6; Craig, Jonathan C.1,8; Pellegrini, Fabio9; Lucisano, Giuseppe6; Hegbrant, Jörgen2; Ariano, Rosario10; Lamacchia, Olga11; Sasso, Antonio12; Morano, Susanna13; Filardi, Tiziana13; De Cosmo, Salvatore14; Pugliese, Giuseppe15; Procaccini, Deni A.16; Gesualdo, Loreto4; Palasciano, Giuseppe17; Johnson, David W.18; Tonelli, Marcello19; Strippoli, Giovanni F.M.1,2,4,20;  on behalf of the Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators

Author Information
Journal of the American Society of Nephrology 29(12):p 2890-2899, December 2018. | DOI: 10.1681/ASN.2018040443
  • Buy
  • Infographic
  • SDC
  • SDC

Abstract

Copyright © 2018 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid